(Q42754658)

6 November 2017

Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression (English)

1 reference

6 November 2017

1 reference

1 reference

1 reference

2

1 reference

6 November 2017

de Vries TJ

1

1 reference

6 November 2017

Denijn M

3

1 reference

6 November 2017

Verrijp KN

4

1 reference

6 November 2017

Verheijen JH

5

1 reference

6 November 2017

Verspaget HW

6

1 reference

6 November 2017

Weidle UH

7

1 reference

6 November 2017

Ruiter DJ

8

1 reference

6 November 2017

van Muijen GN

9

1 reference

6 November 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

The American Journal of Pathology

6 November 2017

1 reference

6 November 2017

144

1 reference

6 November 2017

70-81

1 reference

6 November 2017

1

1 reference

Biology and biochemistry of proteinases in tumor invasion.

6 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Plasminogen activator inhibitors

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Autocrine saturation of pro-urokinase receptors on human A431 cells.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Plasminogen activators, tissue degradation, and cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Proteolytic degradation of extracellular matrix in tumor invasion

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H-ras-transformed NIH 3T3 cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Metalloproteinases and their inhibitors in matrix remodeling

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Imbalance of plasminogen activators and their inhibitors in human colorectal neoplasia. Implications of urokinase in colorectal carcinogenesis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Directed plasminogen activation at the surface of normal and malignant cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Differential protease expression by cutaneous squamous and basal cell carcinomas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Immunolocalization of urokinase-type plasminogen activator in adenomas and carcinomas of the colorectum.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Type-1 plasminogen activator inhibitor in human breast carcinomas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Complementation between urokinase-producing and receptor-producing cells in extracellular matrix degradation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Urokinase plasminogen activator is immunocytochemically detectable in squamous cell but not basal cell carcinomas

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1887106

Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues

16 August 2018

1 reference

12 December 2020

Antibodies to plasminogen activator inhibit human tumor metastasis

1 reference

12 December 2020

Plasminogen activators in human malignant melanoma

1 reference

12 December 2020

Localization of plasminogen activators in human colon cancer by immunoperoxidase staining

1 reference

12 December 2020

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA

1 reference

12 December 2020

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

12 December 2020

Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo

1 reference

12 December 2020

Plasminogen activator profiles in neoplastic tissues of the human colon

1 reference

12 December 2020

Tissue plasminogen activator and inhibitors of fibrinolysis in malignant melanoma

1 reference

12 December 2020

Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts

1 reference

12 December 2020

Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines

1 reference

12 December 2020

Detection of calcitonin-encoding mRNA by radioactive and non-radioactive in situ hybridization: improved colorimetric detection and cellular localization of mRNA in thyroid sections

1 reference

12 December 2020

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer

1 reference

12 December 2020

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

1 reference

12 December 2020

Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells

1 reference

12 December 2020

The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI-1 is located in endothelial cells in the tumor stroma

1 reference

12 December 2020

Identifiers

1 reference

6 November 2017

1 reference